Effectiveness comparison The numbers speak clearly
Research has demonstrated that SCFAs stimulate GLP-1 secretion, highlighting the connection between dietary fiber intake, gut microbiota activity, and metabolic health
Provider-Guided Decision-Making: Who Candidates and Contraindications Compounded semaglutide is appropriate for patients with type 2 diabetes or obesity-related conditions who have been evaluated by a qualified healthcare provider
While not specific to semaglutide, these cases highlight the dangers of using compounded medications without proper oversight
Qsymia is a combination of two older medications that together produce meaningful weight loss (~811% of body weight)
In the analysis, temporary reversal of prediabetes was established as an effect of the interventions, differentiating between patients with and without CVD, based on data from the STEP 1 study [36] and the SELECT study (SELECT study data on-file), respectively (Table S3)